Press release
Female Contraceptive Market worth $14.40 billion by 2030, growing at a CAGR of 6.39% - Exclusive Report by 360iResearch
Female Contraceptive Market | 360iResearch
Request Sample Copy of this Report @ https://www.360iresearch.com/library/intelligence/female-contraceptive?utm_source=openpr&utm_medium=referral&utm_campaign=sample
Market Segmentation & Coverage:
This research report categorizes the Female Contraceptive Market in order to forecast the revenues and analyze trends in each of following sub-markets:
Based on Contraceptive Drug, market is studied across Contraceptive Injections, Contraceptive Pills, Spermicides, and Topical Contraceptives. The Contraceptive Pills is further studied across Hormonal Pills and Non-Hormonal Pills. The Spermicides is projected to witness significant market share during forecast period.
Based on Contraceptive Devices, market is studied across Contraceptive Patches, Contraceptive Sponges, Diaphragms & Caps, Female Condoms, Intra Uterine Contraceptive Devices, Sub-Dermal Contraceptive Implants, and Vaginal Rings. The Intra Uterine Contraceptive Devices is projected to witness significant market share during forecast period.
Based on Distribution Channel, market is studied across Clinic, Hospital Pharmacy, Independent Pharmacy, and Online Platform. The Hospital Pharmacy is projected to witness significant market share during forecast period.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.
FPNV Positioning Matrix:
The FPNV Positioning Matrix is essential for assessing the Female Contraceptive Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).
Market Share Analysis:
The Market Share Analysis offers an insightful look at the current state of vendors in the Female Contraceptive Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.
Key Company Profiles:
The report delves into recent significant developments in the Female Contraceptive Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Afaxys Pharma, LLC, Agile Therapeutics, Amgen Inc., Ansell Ltd., Bayer AG, Cipla Limited, Cupid Limited, HLL Lifecare Limited, Johnson & Johnson Services, Inc., Mankind Pharma Ltd., Merck & Co., Inc., Mithra Pharmaceuticals S.A., Pfizer Inc., and The Cooper Companies, Inc..
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Female Contraceptive Market, by Contraceptive Drug
7. Female Contraceptive Market, by Contraceptive Devices
8. Female Contraceptive Market, by Distribution Channel
9. Americas Female Contraceptive Market
10. Asia-Pacific Female Contraceptive Market
11. Europe, Middle East & Africa Female Contraceptive Market
12. Competitive Landscape
13. Competitive Portfolio
14. Appendix
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Female Contraceptive Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Female Contraceptive Market?
3. What is the competitive strategic window for opportunities in the Female Contraceptive Market?
4. What are the technology trends and regulatory frameworks in the Female Contraceptive Market?
5. What is the market share of the leading vendors in the Female Contraceptive Market?
6. What modes and strategic moves are considered suitable for entering the Female Contraceptive Market?
Read More @ https://www.360iresearch.com/library/intelligence/female-contraceptive?utm_source=openpr&utm_medium=referral&utm_campaign=analyst
Contact 360iResearch
Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550
About 360iResearch
360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.
We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.
Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.
Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Female Contraceptive Market worth $14.40 billion by 2030, growing at a CAGR of 6.39% - Exclusive Report by 360iResearch here
News-ID: 3232881 • Views: …
More Releases from 360iResearch
Prepackaged Medical Kits & Trays Market worth $52.13 billion by 2030, growing at …
The "Prepackaged Medical Kits & Trays Market by Product Type (Admission Kits, Anesthesia Kits, Angiography & Angioplasty Kits), End-User (Academic Research Institutes, Ambulatory Surgical Centers, Clinics) - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.
Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/prepackaged-medical-kits-trays?utm_source=openpr&utm_medium=referral&utm_campaign=sample
"Key Drivers Catalyzing the Growth of the Prepackaged Medical Kits and Trays Market"
The escalating demand for efficient and safe medical procedures is significantly boosting the market for prepackaged…
Hand Geometry Biometrics Market worth $216.26 million by 2030, growing at a CAGR …
The "Hand Geometry Biometrics Market by Type (Biometric Software, Palm Scanner), End-user (BFSI, Building & Construction, Consumer Electronics), Application - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.
Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/hand-geometry-biometrics?utm_source=openpr&utm_medium=referral&utm_campaign=sample
"Hand Geometry Biometrics Market Growth Fuelled by Security Demands and Technological Integrations"
As global security concerns intensify, industries such as banking, healthcare, and government are increasingly adopting hand geometry biometrics for secure, tamper-resistant authentication. This surge…
Satellite IoT Market worth $5.73 billion by 2030, growing at a CAGR of 20.30% - …
The "Satellite IoT Market by Service Type (Direct to Satellite Services, Sat-IoT Backhaul Services), Frequency Band (Ka-band, Ku-band, L-band), End-Use - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.
The Global Satellite IoT Market to grow from USD 1.57 billion in 2023 to USD 5.73 billion by 2030, at a CAGR of 20.30%.
Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/satellite-iot?utm_source=openpr&utm_medium=referral&utm_campaign=sample
The utilization of satellite IoT is significantly growing across various regions,…
Laboratory Chemicals Market worth $40.97 billion by 2030, growing at a CAGR of 8 …
The "Laboratory Chemicals Market by Type (Biochemistry, Carbohydrate Analysis, Cell/Tissue Culture), Application (Academia/Educational, Government, Healthcare & Pharmaceutical) - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.
The Global Laboratory Chemicals Market to grow from USD 22.41 billion in 2023 to USD 40.97 billion by 2030, at a CAGR of 8.99%.
Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/laboratory-chemicals?utm_source=openpr&utm_medium=referral&utm_campaign=sample
Laboratory chemicals include acids, solvents, reagents, and analytical standards for testing and experiments. Laboratory…
More Releases for Contraceptive
Contraceptive Rings Market Segmentation By product type Etonogestrel/Ethinyl est …
Contraceptive rings are smooth, flexible round shaped plastic rings which are meant to insert into vagina to on first day woman’s menstrual cycle to prevent possible pregnancy. When contraceptive rings are placed into the vagina it releases two hormones named estrogen and progestogen which are similar to natural hormones released by the body and which are also used in the contraceptive pills. Contraceptive rings release continuous dose of these hormones…
Contraceptive Pills
Oral contraceptive pills is a kind of female hormonal anti-conception medication technique that is used for avoiding pregnancy. Contraceptive drugs are used to prevent the unwanted pregnancy by blocking the normal process of ovulations or by altering the process which support the fertilization of egg. The prevalence of women with unmet contraception needs was accounted at 214 million in 2018 by WHO. Further, as indicated by, United Nations,…
Contraceptive Rings Market Segmentation By product type Etonogestrel/Ethinyl est …
Contraceptive rings are smooth, flexible round shaped plastic rings which are meant to insert into vagina to on first day woman’s menstrual cycle to prevent possible pregnancy. When contraceptive rings are placed into the vagina it releases two hormones named estrogen and progestogen which are similar to natural hormones released by the body and which are also used in the contraceptive pills. Contraceptive rings release continuous dose of these hormones…
U.S. Contraceptives Drugs And Devices Market, By Product Type (Contraceptive Dru …
Contraceptive Drugs and Devices – Choice to Conceive, Not Concede
As per stats released by Guttmacher Institute, there were around 61 million women in the U.S. in the childbearing age group (15-44 years) in 2014. Around 10% of these women do not use any contraceptive method. The UN estimates (2015) that unmet need for contraceptives in the North America region is 7%. Thus, there still is an untapped market in the…
Global Contraceptives Drugs And Devices Market, By Product Type (Contraceptive D …
Contraceptives are birth spacing products that aid in avoiding unwanted/ unplanned pregnancy. There are five widely used contraceptive methods namely barrier method, hormonal method, emergency contraception, intrauterine method, and sterilization. Women can opt for wide range of contraceptive options such as vaginal rings, diaphragms, female condoms, oral pills, and intra-uterine devices (IUD). Selecting the most appropriate method is critical to avoid undesired side effects. The use of contraceptives can avoid…
Oral Contraceptive Pills Market: Snapshot
Teva Pharmaceutical is one of the leading companies in the combination oral contraceptive pills segment and is followed by Allergan (Actavis) plc. Local manufacturers such as Alkem, Taj Pharma, and Zydus Alidec on the other hand, held a majority of the market for ormeloxifene and mifepristone. Transparency Market Research has observed that almost all manufacturers offer combination oral contraceptive pills owing to the fact that they are more efficient, cost…
